Regeneron

GSK and Regeneron to mine gene data from 500,000 Britons
Yahoo/Reuters
Wed, 03/22/17 - 10:33 pm
GSK
Regeneron
data mining
UK
DNA
Sanofi, Regeneron Sue Amgen to Avoid Dupixent Patent Claims
Investopedia
Wed, 03/22/17 - 09:58 am
Sanofi
Regeneron
Dupixent
Amgen
patents
eczema
Sanofi, Regeneron say latest Dupixent eczema drug tests positive
Yahoo/Reuters
Sat, 03/4/17 - 01:54 pm
Sanofi
Regeneron
Dupixent
eczema
clinical trials
Sanofi confident in case to overturn Praluent ban
BioPharma Dive
Sat, 02/11/17 - 12:47 pm
Sanofi
Praluent
Regeneron
Amgen
Repatha
Regeneron revenue rises 11.7 pct on Eylea eye drug
Yahoo/Reuters
Thu, 02/9/17 - 11:18 am
Regeneron
earnings
Eylea
Sanofi, Regeneron win a crucial stay of execution on Praluent
Endpoints
Wed, 02/8/17 - 09:36 pm
Sanofi
Regeneron
Praluent
Amgen
Repatha
Earnings Preview: What To Expect From Regeneron On Thursday
Forbes
Wed, 02/8/17 - 09:29 am
Regeneron
earnings
When it comes to PCSK9s, payers resisted — and sales flopped
Medical Marketing and Media
Wed, 01/11/17 - 09:54 am
PCSK9 inhibitors
payers
Amgen
Sanofi
Regeneron
Repatha
Praluent
Regeneron CEO says Amgen not putting patients first in patent dispute
Yahoo/Reuters
Tue, 01/10/17 - 09:19 am
Regeneron
Pharma CEOs
Amgen
Sanofi
patents
Repatha
Praluent
Len Schleifer
2 Top Stocks in Biotech
Motley Fool
Mon, 01/9/17 - 09:47 am
biotech
Portola Pharmaceuticals
Regeneron
Judge’s unusual ruling on Amgen, Regeneron patent case puts billions of dollars at stake
Marketwatch
Sun, 01/8/17 - 03:32 pm
Amgen
Sanofi
Regeneron
Repatha
Praluent
Regeneron and Sanofi to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Praluent® (alirocumab) Injection
Yahoo
Fri, 01/6/17 - 10:22 am
Regeneron
Sanofi
Amgen
patents
Repatha
Praluent
Amgen Wins Ban on Sanofi’s Praluent Cholesterol Drug Sales
Bloomberg
Fri, 01/6/17 - 09:51 am
Amgen
Sanofi
Regeneron
Praluent
Repatha
patents
Sanofi, Regeneron one step closer to owing PCSK9 royalties as judge upholds Amgen patent ruling
Fierce Pharma
Thu, 01/5/17 - 09:20 am
Sanofi
Regeneron
PCSK9 inhibitors
Amgen
Praluent
Repatha
Biotech Stocks: What to Watch in 2017
Motley Fool
Tue, 01/3/17 - 10:02 am
biotech
M&A
drug launches
Gilead Sciences
Incyte
Spinraza
Biogen
Ionis Pharmaceuticals
Amgen
Regeneron
Sanofi
Regeneron Eyes A Comeback In 2017
Yahoo/Benzinga
Wed, 12/28/16 - 11:37 am
Regeneron
Once-promising diabetes ‘breakthrough’ comes unglued with a major retraction
Stat
Wed, 12/28/16 - 11:09 am
diabetes
stem cells
Regeneron
Biotechs line up to tap growing ophthalmics market
BioPharma Dive
Thu, 12/22/16 - 10:25 am
Ophthalmic Drugs Market
Ocular Therapeutix
Eylea
Restasis
Lucentis
Regeneron
Roche
Allergan
Amgen, Regeneron May Yet Get Rich From Their Cholesterol Drugs
Seeking Alpha
Tue, 12/20/16 - 12:04 pm
Amgen
Regeneron
Praluent
Repatha
Sanofi
Reeling Ophthotech eviscerates staff, laying off up to 135; Booming Regeneron adds more space
Endpoints
Fri, 12/16/16 - 09:50 am
Ophthotech
layoffs
Fovista
Regeneron

Pages